SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

35 hedge funds and large institutions have $108M invested in Sinovac Biotech, Ltd in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.6M
2
+$886K
3
+$519K
4
Two Sigma Investments
Two Sigma Investments
New York
+$432K
5
Millennium Management
Millennium Management
New York
+$320K

Top Sellers

1
-$31.7M
2
-$2.04M
3
-$398K
4
TC
TFS Capital
Pennsylvania
-$157K
5
FIM
Freedom Investment Management
Connecticut
-$110K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$14K
27
$10K
28
$7K
29
$6K
30
$6K
31
$4K
32
$3K
33
$3K
34
$2K
35
$1K
36
–
37
–
38
–
39
–
40
–
41
–
42
–
1
2